http://purl.uniprot.org/citations/36889044 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
http://purl.uniprot.org/citations/36889044 | http://www.w3.org/2000/01/rdf-schema#comment | "Phenotype-gene analyses and the increasing availability of mega-databases have revealed the impaired human flavin-containing monooxygenase 3 (FMO3) variants associated with the metabolic disorder trimethylaminuria. In this study, a novel compound variant of FMO3, p.[(Val58Ile; Tyr229His)], was identified in a 1-year-old Japanese girl who had impaired FMO3 metabolic capacity (70%) in terms of urinary trimethylamine N-oxide excretion levels divided by total levels of trimethylamine and its N-oxide. One cousin in the family had the same p.[(Val58Ile); (Tyr229His)]; [(Glu158Lys; Glu308Gly)] FMO3 haplotype and had a similar FMO3 metabolic capacity (69%). In a family study, the novel p.[(Val58Ile); (Tyr229His)] compound FMO3 variant was also detected in the proband 1's mother and aunt. Another novel compound FMO3 variant p.[(Glu158Lys; Met260Lys; Glu308Gly; Ile426Thr)] was identified in a 7-year-old girl, proband 2. This novel compound FMO3 variant was inherited from her mother. Recombinant FMO3 Val58Ile; Tyr229His variant and Glu158Lys; Met260Lys; Glu308Gly; Ile426Thr variant showed moderately decreased capacities for trimethylamine N-oxygenation compared to wild-type FMO3. Analysis of trimethylaminuria phenotypes in family studies has revealed compound missense FMO3 variants that impair FMO3-mediated N-oxygenation in Japanese subjects; moreover, these variants could result in modified drug clearances."xsd:string |
http://purl.uniprot.org/citations/36889044 | http://purl.org/dc/terms/identifier | "doi:10.1016/j.dmpk.2023.100490"xsd:string |
http://purl.uniprot.org/citations/36889044 | http://purl.uniprot.org/core/author | "Shimizu M."xsd:string |
http://purl.uniprot.org/citations/36889044 | http://purl.uniprot.org/core/author | "Yamamoto A."xsd:string |
http://purl.uniprot.org/citations/36889044 | http://purl.uniprot.org/core/author | "Yamazaki H."xsd:string |
http://purl.uniprot.org/citations/36889044 | http://purl.uniprot.org/core/author | "Yokota Y."xsd:string |
http://purl.uniprot.org/citations/36889044 | http://purl.uniprot.org/core/author | "Harano M."xsd:string |
http://purl.uniprot.org/citations/36889044 | http://purl.uniprot.org/core/author | "Makiguchi M."xsd:string |
http://purl.uniprot.org/citations/36889044 | http://purl.uniprot.org/core/author | "Shimamura E."xsd:string |
http://purl.uniprot.org/citations/36889044 | http://purl.uniprot.org/core/date | "2023"xsd:gYear |
http://purl.uniprot.org/citations/36889044 | http://purl.uniprot.org/core/name | "Drug Metab Pharmacokinet"xsd:string |
http://purl.uniprot.org/citations/36889044 | http://purl.uniprot.org/core/pages | "100490"xsd:string |
http://purl.uniprot.org/citations/36889044 | http://purl.uniprot.org/core/title | "A family study of compound variants of flavin-containing monooxygenase 3 (FMO3) in Japanese subjects found by urinary phenotyping for trimethylaminuria."xsd:string |
http://purl.uniprot.org/citations/36889044 | http://purl.uniprot.org/core/volume | "50"xsd:string |
http://purl.uniprot.org/citations/36889044 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/36889044 |
http://purl.uniprot.org/citations/36889044 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/36889044 |
http://purl.uniprot.org/uniprot/#_A0A024R8Z4-mappedCitation-36889044 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/36889044 |
http://purl.uniprot.org/uniprot/#_A0A0S2Z3R0-mappedCitation-36889044 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/36889044 |
http://purl.uniprot.org/uniprot/#_B7Z3M2-mappedCitation-36889044 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/36889044 |
http://purl.uniprot.org/uniprot/#_B7Z543-mappedCitation-36889044 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/36889044 |
http://purl.uniprot.org/uniprot/#_P31513-mappedCitation-36889044 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/36889044 |
http://purl.uniprot.org/uniprot/#_Q53FW5-mappedCitation-36889044 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/36889044 |
http://purl.uniprot.org/uniprot/Q53FW5 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/36889044 |
http://purl.uniprot.org/uniprot/A0A0S2Z3R0 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/36889044 |